HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Clinical trials for HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS explained in plain language.

Never miss a new study

Get alerted when new HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

Sign up with your email to follow new studies for HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug may help kids with rare immune disease reach life-saving transplant

Disease control Recruiting now

This study tests a drug called ruxolitinib as the first treatment for children with primary haemophagocytic lymphohistiocytosis (HLH), a rare and serious immune disorder. The goal is to see if ruxolitinib, given with steroids, can help children survive long enough to receive a st…

Matched conditions: HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Apr 28, 2026 13:01 UTC

HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Get alerted when new HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear

New drug may help kids with rare immune disease reach life-saving transplant